227 related articles for article (PubMed ID: 18054102)
1. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations.
van Elmpt W; Nijsten S; Mijnheer B; Dekker A; Lambin P
Radiother Oncol; 2008 Jan; 86(1):86-92. PubMed ID: 18054102
[TBL] [Abstract][Full Text] [Related]
2. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
van Zijtveld M; Dirkx ML; de Boer HC; Heijmen BJ
Radiother Oncol; 2007 Feb; 82(2):201-7. PubMed ID: 17287039
[TBL] [Abstract][Full Text] [Related]
3. Head-and-neck IMRT treatments assessed with a Monte Carlo dose calculation engine.
Seco J; Adams E; Bidmead M; Partridge M; Verhaegen F
Phys Med Biol; 2005 Mar; 50(5):817-30. PubMed ID: 15798257
[TBL] [Abstract][Full Text] [Related]
4. Treatment verification in the presence of inhomogeneities using EPID-based three-dimensional dose reconstruction.
van Elmpt WJ; Nijsten SM; Dekker AL; Mijnheer BJ; Lambin P
Med Phys; 2007 Jul; 34(7):2816-26. PubMed ID: 17821989
[TBL] [Abstract][Full Text] [Related]
5. 3D in vivo dose verification of entire hypo-fractionated IMRT treatments using an EPID and cone-beam CT.
McDermott LN; Wendling M; Nijkamp J; Mans A; Sonke JJ; Mijnheer BJ; van Herk M
Radiother Oncol; 2008 Jan; 86(1):35-42. PubMed ID: 18061692
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo-based dosimetry of head-and-neck patients treated with SIB-IMRT.
Sakthi N; Keall P; Mihaylov I; Wu Q; Wu Y; Williamson JF; Schmidt-Ullrich R; Siebers JV
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):968-77. PubMed ID: 16458782
[TBL] [Abstract][Full Text] [Related]
7. Agreement criteria between expected and measured field fluences in IMRT of head and neck cancer: the importance and use of the gamma histograms statistical analysis.
De Martin E; Fiorino C; Broggi S; Longobardi B; Pierelli A; Perna L; Cattaneo GM; Calandrino R
Radiother Oncol; 2007 Dec; 85(3):399-406. PubMed ID: 17980925
[TBL] [Abstract][Full Text] [Related]
8. Fast 3D dosimetric verifications based on an electronic portal imaging device using a GPU calculation engine.
Zhu J; Chen L; Chen A; Luo G; Deng X; Liu X
Radiat Oncol; 2015 Apr; 10():85. PubMed ID: 25885567
[TBL] [Abstract][Full Text] [Related]
9. IMRT head and neck treatment planning with a commercially available Monte Carlo based planning system.
Boudreau C; Heath E; Seuntjens J; Ballivy O; Parker W
Phys Med Biol; 2005 Mar; 50(5):879-90. PubMed ID: 15798262
[TBL] [Abstract][Full Text] [Related]
10. Experimental measurements and Monte Carlo simulations for dosimetric evaluations of intrafraction motion for gated and ungated intensity modulated arc therapy deliveries.
Oliver M; Gladwish A; Staruch R; Craig J; Gaede S; Chen J; Wong E
Phys Med Biol; 2008 Nov; 53(22):6419-36. PubMed ID: 18941277
[TBL] [Abstract][Full Text] [Related]
11. Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience.
Georg D; Stock M; Kroupa B; Olofsson J; Nyholm T; Ahnesjö A; Karlsson M
Phys Med Biol; 2007 Aug; 52(16):4981-92. PubMed ID: 17671348
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification.
Bragg CM; Wingate K; Conway J
Radiother Oncol; 2008 Feb; 86(2):276-84. PubMed ID: 18249453
[TBL] [Abstract][Full Text] [Related]
13. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo-based procedure for independent monitor unit calculation in IMRT treatment plans.
Pisaturo O; Moeckli R; Mirimanoff RO; Bochud FO
Phys Med Biol; 2009 Jul; 54(13):4299-310. PubMed ID: 19531844
[TBL] [Abstract][Full Text] [Related]
15. 3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry.
Mans A; Remeijer P; Olaciregui-Ruiz I; Wendling M; Sonke JJ; Mijnheer B; van Herk M; Stroom JC
Radiother Oncol; 2010 Feb; 94(2):181-7. PubMed ID: 20089323
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of uncertainty-based stopping criteria for monte carlo calculations of intensity-modulated radiotherapy and arc therapy patient dose distributions.
Vanderstraeten B; Olteanu AM; Reynaert N; Leal A; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):628-37. PubMed ID: 17869677
[TBL] [Abstract][Full Text] [Related]
18. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
Jarry G; Verhaegen F
Phys Med Biol; 2007 Apr; 52(8):2277-99. PubMed ID: 17404469
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
Flampouri S; Jiang SB; Sharp GC; Wolfgang J; Patel AA; Choi NC
Phys Med Biol; 2006 Jun; 51(11):2763-79. PubMed ID: 16723765
[TBL] [Abstract][Full Text] [Related]
20. Automated selection of beam orientations and segmented intensity-modulated radiotherapy (IMRT) for treatment of oesophagus tumors.
Woudstra E; Heijmen BJ; Storchi PR
Radiother Oncol; 2005 Dec; 77(3):254-61. PubMed ID: 16026873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
